about
Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptidesCommon variable immunodeficiency. Old questions are getting clearerInfluence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study.Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patientsHuman colon-derived soluble factors modulate gut microbiota composition.Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum.Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal ColonCeliac disease pathogenesis: the proinflammatory cytokine network.High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBDFecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.Innate lymphoid cells and natural killer T cells in the gastrointestinal tract immune system.Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions.Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients.Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer.Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species.Are Worries and Concerns Information Side Effects?Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine.Persistence of proinflammatory response after severe respiratory syncytial virus disease in children.Association of the IL-15 and IL-15Rα genes with celiac disease.Celiac disease diagnosis in patients with giardiasis: high value of antitransglutaminase antibodies.High cord blood IL-10 levels in preterm newborns with respiratory distress syndrome.Human corneal fibroblast migration and extracellular matrix synthesis during stromal repair: Role played by platelet-derived growth factor-BB, basic fibroblast growth factor, and transforming growth factor-β1.New IL-15 receptor-α splicing variants identified in intestinal epithelial Caco-2 cells.Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.Hypogalactosylation of serum IgG in patients with coeliac disease.Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: the PROFICEL study.The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis.Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.Altered expression of the lymphocyte activation antigen CD30 in active celiac disease.Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients.Interleukin (IL)-1beta, IL-6 and IL-8 in nasal secretions: a common role for innate immunity in viral bronchial infection in infants?Antibody levels to Bordetella pertussis in 10-yr-old children with atopy and atopic asthmaThe HLA-DRB4 gene is present in half of the Spanish HLA-DQ2-negative celiac patientsOne-step immunochromatographic assay for screening of coeliac diseaseA novel visual immunoassay for coeliac disease screeningTNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive populationInterleukin 18 maintains a long-standing inflammation in coeliac disease patients[Cytokines and other immunological parameters as markers of distant organ involvement in acute pancreatitis][Cytokines in the pathogeny of celiac disease]IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients
P50
Q24674588-720FDA6A-D7B6-447D-BA06-6705C87CAF7AQ28279348-5789406D-C8C1-4769-9C35-A081603626DCQ34154669-7B537B26-B8AA-4F7A-844F-F8E6D0D7CECEQ35053807-D7955110-DCD7-40E5-B063-221CDC65473FQ35383897-FB2755E1-5431-4CC4-96E4-D95DF524CB09Q36329777-250D0A27-C746-4D81-A94D-594A1D011D9FQ36443933-3883655F-E7F0-4787-9EF6-E83CD5A27466Q37230861-00300FDD-F6A4-4256-A2A9-460BDC85899BQ37286157-439F564F-1B6B-426E-8946-D36F0942C50BQ37330452-1C24E32C-52DC-4936-AE2D-EC0C3C30DE07Q38257160-E79981CF-3015-460F-9621-25FC7AC93411Q39214951-804774AC-09F7-4609-86DD-242188EA9031Q39770051-B55CE447-BD13-420C-A611-37000F76CDFFQ41006893-FABEC836-52EE-4880-8C94-4511DC913EAEQ42198341-AD5CA9AC-1BA8-4AFF-A53A-8263CD5FE74AQ44235612-D81EC28D-CCD9-4692-9493-886238D39A03Q44455167-92E3344A-7420-41F4-A3F6-71CF2D8B58DFQ45404849-C4FA3DA1-BCC6-494D-A726-FEC972B0CF11Q47201573-C6D99ACD-7E9D-4631-B80E-9B3E3A569393Q47249855-DF6397FB-81C0-4A5A-8AE4-DE9A90BCD537Q47938066-DEA7CCD2-D343-484A-9E67-38FDA2DBCE0CQ51061314-F4308A40-3CFE-4471-9D19-B11C90898B58Q51355809-98429701-87BD-4BC8-8611-AAE4FF5D55ABQ51673354-8E93ADCE-2BC3-40D9-9FB1-0B0FBA35902CQ51833969-22E62DD5-9DEB-43E9-B49B-2A4DC5BBB97FQ52578126-B9729B02-A2BB-487F-8B26-8452ED8786B0Q53298027-8C20A170-A1DF-4E90-A120-ABB072BDF4A0Q53303903-5BC703A8-DA08-40BD-A771-26F20DC141AEQ53341128-498C5E46-8C11-4D37-88E9-E128A85EED7AQ55603579-6886D9A4-A83A-4D85-8F07-893F28802609Q57276218-A67411EA-9C6D-42AC-8C13-47AB86B7EF3BQ59737375-208B12E9-32B5-4079-AD42-1C0216B9C392Q73147859-9A23FC0F-C11F-4D0D-A3A9-0B632D3DDD65Q77835153-9C2A6178-3B69-4A5D-8961-67F7961F74DCQ78157621-13DAE5FF-2E79-455B-A476-5B890790F60AQ78536745-2BC13627-9EB3-4D61-B69A-181C470DE5FBQ79353317-D0381624-D347-437D-A727-6923E4DF0C9DQ80063450-C3CB8F08-507E-4351-A0B5-4C4ED63CF5E6Q81379310-52B346EC-8FAF-43FC-8095-8D44C18C6125Q81479889-29A7073D-9829-4AD7-AA87-73EEDD63CC2A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
José Antonio Garrote
@ast
José Antonio Garrote
@en
José Antonio Garrote
@es
José Antonio Garrote
@nl
José Antonio Garrote
@sl
type
label
José Antonio Garrote
@ast
José Antonio Garrote
@en
José Antonio Garrote
@es
José Antonio Garrote
@nl
José Antonio Garrote
@sl
prefLabel
José Antonio Garrote
@ast
José Antonio Garrote
@en
José Antonio Garrote
@es
José Antonio Garrote
@nl
José Antonio Garrote
@sl
P108
P106
P1153
6603864059
P21
P31
P496
0000-0003-1797-6520